These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6868461)

  • 1. [Effect of ultrasound on the physicochemical properties of hydroxyprogesterone capronate (an experimental study)].
    Grigor'eva VD; Sapozhnikov VV
    Vopr Kurortol Fizioter Lech Fiz Kult; 1983; (2):33-5. PubMed ID: 6868461
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacology of new gestagens: derivatives of 17-alpha-hydroxyprogesterone].
    Nikitina GV
    Farmakol Toksikol; 1989; 52(3):44-7. PubMed ID: 2792352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Physicochemical basis for proserine electrophoresis using sinusoidal modulated currents].
    Danilova IN; Sharpanova IK; Minenkov AA
    Vopr Kurortol Fizioter Lech Fiz Kult; 1983; (2):36-8. PubMed ID: 6868462
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hormonal therapy of cancer of the corpus uteri].
    Nigaĭ SV; Smakhtina OL; Kozbagarova RG; Nigmatullina AA
    Vopr Onkol; 1983; 29(3):22-6. PubMed ID: 6836982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oxyprogesterone capronate in the treatment of menstrual epilepsy].
    Badalian LO; Temin PA; Mukhin KIu
    Ross Med Zh; 1992; (3):41-4. PubMed ID: 1643360
    [No Abstract]   [Full Text] [Related]  

  • 6. High-performance liquid chromatographic analysis of the by-products of the synthesis of ethynylestradiol, mestranol, 17 alpha-hydroxy-progesterone caproate and 17 alpha-hydroxy-6-dehydroprogesterone acetate.
    Levtchenko NK; Osokin DM; Torgov IV; Arzamastzev AP; Sokolova TM; Tuguntaev GI
    J Chromatogr; 1988 Dec; 456(2):427-30. PubMed ID: 3243879
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of 17-alpha-hydroxprogesterone-capronate in certain malignant tumors].
    Garin AM; Voznyĭ EK; Borisov VI; Dobrushina VA; Lazovskaia EB
    Klin Med (Mosk); 1974 Mar; 52(3):121-3. PubMed ID: 4466932
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of the barrier properties of mucosal membranes.
    Corbo DC; Liu JC; Chien YW
    J Pharm Sci; 1990 Mar; 79(3):202-6. PubMed ID: 2338626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The comparative effects of progesterone and 17-hydroxyprogesterone capronate on the incroporation of H3-thymidine and H3-uridine into the nuclei of Hela cells].
    Blokhina EM; Zelenina IA
    Farmakol Toksikol; 1973; 36(5):592-5. PubMed ID: 4788070
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of 17-hydroxy progesterone caproate, flutamide & cyproterone acetate on genital organs & fertility of male rats--a comparative study.
    Das RP; Roy S; Kumari GL
    Indian J Exp Biol; 1980 Nov; 18(11):1225-9. PubMed ID: 6452409
    [No Abstract]   [Full Text] [Related]  

  • 11. [Endocrinologic action spectrum of 19-nor-17-alpha-hydroxyprogesterone capronate (Gestonorone capronate)].
    Neumann F; Kramer M; Raspé G
    Arzneimittelforschung; 1968 Oct; 18(10):1289-97. PubMed ID: 5755710
    [No Abstract]   [Full Text] [Related]  

  • 12. [Potential and efficacy of the therapeutic use of beta-adrenoblockader electrophoresis (an experimental study)].
    Levchenko NF; Danilova IN; Sharpanova IK
    Vopr Kurortol Fizioter Lech Fiz Kult; 1981; (1):49-52. PubMed ID: 6111862
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of the clinical effectiveness of 17-hydroxyprogesterone capronate (Hormofort)].
    Sas M; Farkas M; Szegvári M
    Orv Hetil; 1967 Jun; 108(23):1066-9. PubMed ID: 5624867
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biotechnical increase of litter size in early pregnant sows using steroid application. 1. The effect of a single application of hydroxyprogesterone capronate on fertility response in ovulation-synchronized gilts and old sows].
    Nowak P; Hühn U; Heidler W; Tschirner R; Thiel J; Packebusch K
    Arch Exp Veterinarmed; 1978; 32(6):855-61. PubMed ID: 749736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 17alpha-hydroxy-progesterone effects on cervical proinflammatory agents in women at risk for preterm delivery.
    Facchinetti F; Dante G; Venturini P; Paganelli S; Volpe A
    Am J Perinatol; 2008 Sep; 25(8):503-6. PubMed ID: 18756431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacology of progestins].
    Michel G; Kuttenn F
    Rev Prat; 1981 Apr; 31(19):1333-47. PubMed ID: 7233015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of 17-alpha-hydroxy-progesterone capronate on the motility of the human uterus in puerperium following abortion].
    Data PG; Morra C; Lanza A; Scaramuzza P
    Boll Soc Ital Biol Sper; 1973 Mar; 49(9):471-6. PubMed ID: 4787512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental and clinical study of the electrophoresis of drugs with immunodepressive action].
    Zobnina GV; Ulashchik VS
    Vopr Kurortol Fizioter Lech Fiz Kult; 1984; (4):6-9. PubMed ID: 6435310
    [No Abstract]   [Full Text] [Related]  

  • 19. [Incidence of side effects of synthetic progestins with different content of estrogenic and gestagenic components].
    Rotkina IE; Lutsik LA; Dubovik NT
    Akush Ginekol (Mosk); 1977 Sep; (9):29-31. PubMed ID: 596558
    [No Abstract]   [Full Text] [Related]  

  • 20. Further studies on a new bioassay of progestational activity (traumatic deciduoma formation in immature rats).
    Madjerek ZS; Smit-Vis JH
    Acta Morphol Neerl Scand; 1977 Feb; 15(1):65-74. PubMed ID: 72488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.